Usual Clinical Parameters Underestimate the Incidence and Significance of Erythropoietin Deficiency as a Risk Factor for Death in Sickle Cell Disease
Autor: | Stephen Vara, Robert E. Molokie, Mohammed Farooqui, Joseph DeSimone, Yogenthiran Saunthararajah, Santosh L. Saraf, Seema Sidhwani |
---|---|
Rok vydání: | 2007 |
Předmět: |
medicine.medical_specialty
Anemia business.industry Reticulocytosis Thalassemia Immunology Cell Biology Hematology Disease medicine.disease Biochemistry Gastroenterology Erythropoietin hemic and lymphatic diseases Internal medicine medicine Hemoglobin Reticulocytopenia Risk factor medicine.symptom business medicine.drug |
Zdroj: | Blood. 110:3791-3791 |
ISSN: | 1528-0020 0006-4971 |
DOI: | 10.1182/blood.v110.11.3791.3791 |
Popis: | A robust reticulocytosis is necessary to maintain hemoglobin levels compatible with life in patients with sickle cell disease. Relative reticulocytopenia, defined as a absolute reticulocyte count less than 250 x 109/L despite hemoglobin |
Databáze: | OpenAIRE |
Externí odkaz: |